Lb Pharmaceuticals Inc · NASDAQ:LBRX
JPMorgan Chase & Co reported a 5.20% stake in Lb Pharmaceuticals Inc (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 16, 2026
JPMorgan Chase & Co reported a 5.20% stake in Lb Pharmaceuticals Inc, 1,497,293 shares, as a passive investor on Jun 30, 2026. Filed Jul 16, 2026 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 1,497,293
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JPMORGAN CHASE & CO | 5.20% | 1,497,293 |
Source
Related
- Lb Pharmaceuticals Inc
- JPMorgan Chase & Co
- Lb Pharmaceuticals Inc shareholders
- Schedule 13G/A · JPMorgan Chase & Co · Oct 13, 2026
- Schedule 13G/A · JPMorgan Chase & Co · May 13, 2026
- Schedule 13G · JPMorgan Chase & Co · Jan 21, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · May 15, 2026
- Schedule 13G · Caligan Partners LP · May 15, 2026
- Schedule 13G/A · Commodore Capital LP · May 15, 2026